sida/antifonjik

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 66057 rezilta yo

Toward personalized psychotherapy: The importance of the trait-like/state-like distinction for understanding therapeutic change

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

For the past hundred years, mechanisms of change have been the black box of psychotherapy. Thousands of studies failed to produce consistent findings, even concerning factors considered crucial for treatment success by theoretical models and decades of clinical experience. This article introduces

Targeting Toll-like receptors: emerging therapeutics?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

There is a growing interest in the targeting of Toll-like receptors (TLRs) for the prevention and treatment of cancer, rheumatoid arthritis, inflammatory bowel disease and systemic lupus erythematosus (SLE). Several new compounds are now undergoing preclinical and clinical evaluation, with a

A new trichothecin-like antifungal antibiotic.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Glucagon-like peptide: a therapeutic glimmer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Expression of various Toll-like receptors (TLR) in keratinocytes (KCs) has offered new insights into the pathogenesis of psoriasis. When plasmacytoid dendritic cells (pDCs) are scarce in established psoriatic lesions, KCs take the responsibility to secrete IFN type 1 through TLR9

Bioinspired exosome-like therapeutics and delivery nanoplatforms.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Exosomes have emerged as appealing candidate therapeutic agents and delivery nanoplatforms due to their endogenous features and unique biological properties. However, obstacles such as low isolation yield, considerable complexity and potential safety concerns, and inefficient drug payload

Toll-like receptor signaling pathways--therapeutic opportunities.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Toll-like receptors (TLRs) are transmembrane proteins acting mainly as sensors of microbial components. Triggering TLRs results in increased expression of multiple inflammatory genes, which then play a protective role against infection. However, aberrant activation of TLR signaling has a significant

Toll-like receptors and innate antifungal responses.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The mammalian Toll-like receptors (TLRs) are homologues of Drosophila Toll and constitute a novel protein family involved in the mediation of innate immunity and the activation of adaptive immunity. Analysis of infection with human pathogenic fungi Candida albicans and Aspergillus fumigatus

Protective antifungal yeast killer toxin-like antibodies.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

After several years of controversy, antibodies (Abs) are now believed to play an important role in the protection against fungal infections. Among them, recent data are strongly supporting the relevance of protective yeast killer toxin-like Abs ("antibiobodies", KT-Abs), which are able to exert a

The future of toll-like receptor therapeutics.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Since the discovery of human TLRs, manipulating the activity of these receptors to modulate immune responses for therapeutic purposes has initiated intense activity in the pharmaceutical industry. The focus of these activities has been largely in the areas of infectious diseases, cancer, allergic

Antiviral therapeutic intervention in poliomyelitis-like syndrome.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Antifungal peptides, a heat shock protein-like peptide, and a serine-threonine kinase-like protein from Ceylon spinach seeds.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Two antifungal peptides (designated alpha- and beta-basrubrins) with molecular masses of 4-5 kDa and distinct N-terminal sequences, and a peptide and a protein with N-terminal sequences resembling heat shock protein (hsp) and serine-threonine kinase, respectively, were isolated from seeds of the

Fabin, a novel calcyon-like and glucanase-like protein with mitogenic, antifungal and translation-inhibitory activities from broad beans.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A protein with an N-terminal sequence displaying similarities to N-terminal sequences of human calcyon and barley endo-1,4-glucanase, and to C-terminal sequences of human translation initiation factor 4 gamma and yeast superkiller viralicidic activity, was isolated from the broad bean Vicia faba.

Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We compared digoxin-like (DLIS) and digitoxin-like (DTLIS) immunoreactive substance concentrations for 30 people older than 65 years with those for 25 people younger than 50. None received digoxin or had liver disease, uremia, or volume expansion. We found no DTLIS in any specimen, and only 1

Comparing like with like: some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Histories of clinical trials have recorded and analysed the development of quantification in therapeutic evaluation, the emergence of probabilistic thinking, the application of statistical methods and theory, and the sociology, ethics and politics of clinical trials; but it is surprising that they

Previous
1
2
3
4
5
6
...
4403
4404
Next

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye